Self-administration of an intravenous drug for treating and preventing hereditary angioedema (HAE) attacks is safe

0

Intravenous news: MedPage Today report “Self-administration of an intravenous drug for treating and preventing hereditary angioedema (HAE) attacks is safe and feasible, a researcher said here. A total of 13 HAE patients were trained to infuse themselves with a C1 inhibitor product, and most were able to use it without major incident, reported Ralph Shapiro, MD, of Midwest Immunology Clinic in Plymouth, Minn. Only one patient had a problem with the self-infusion in the form of a breakthrough attack that occurred because limb swelling interfered with placing the IV line properly, Shapiro indicated at a poster presentation at the American College of Allergy, Asthma, and Immunology annual meeting.”

Main page

Share.

Comments are closed.